Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00748059 · ClinicalTrials.gov registry record · Phase 1
The Pathophysiology of Orthostatic Hypotension
A Phase 1 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00748059 is a Phase 1 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 10 participants.
The verdict
NCT00748059, a Phase 1 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the cause of low blood pressure in selective patients who have problems with their involuntary (autonomic) nervous system. These patients frequently have had symptoms throughout their life, and their disorder might have a genetic basis. The biochemical, physiological and pharmacological procedures in this study should help us define the problem and perhaps lead to more effective treatment.
Interventions
- PROCEDURE QSweat
- PROCEDURE Microneurography
- PROCEDURE Standing or upright tilt
- DEVICE neck cuff stimulation
- DRUG phenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 1996-12 |
| Est. Completion | 2020-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00748059
The ClinicalTrials.gov registry entry for NCT00748059 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which QSweat is the first listed.
NCT00748059 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00748059 about?
NCT00748059 is a clinical study titled "The Pathophysiology of Orthostatic Hypotension". The purpose of this study is to determine the cause of low blood pressure in selective patients who have problems with their involuntary (autonomic) nervous system. These patients frequently have had symptoms throughout their life, and their disorder might have a genetic basis. The biochemical, phys...
What is the current status of trial NCT00748059?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 1996-12. Estimated completion is 2020-12.
What interventions are being tested in trial NCT00748059?
The interventions under investigation include: QSweat (PROCEDURE), Microneurography (PROCEDURE), Standing or upright tilt (PROCEDURE), neck cuff stimulation (DEVICE), phenylephrine,isoproterenol,nitroprusside,propranolol,edrophonium,atropine,tyramine (DRUG).
Who is sponsoring clinical trial NCT00748059?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.